Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380991779> ?p ?o ?g. }
- W4380991779 endingPage "e003022" @default.
- W4380991779 startingPage "e003022" @default.
- W4380991779 abstract "To better define the spectrum of new-onset post-COVID-19 and post-COVID-19 vaccine inflammatory rheumatic diseases (IRD) from a large multicentric observational study.Consecutive cases of IRD encountered during a 12-month period and satisfying one of the following inclusion criteria: (a) onset of the rheumatic manifestations within 4 weeks from SARS-CoV-2 infection or (b) onset of the rheumatic manifestations within 4 weeks from the administration of one of the COVID-19 vaccines ws recruited.The final analysis cohort comprised 267 patients, of which 122 (45.2%) in the post-COVID-19 and 145 (54.8%) in the postvaccine cohort. Distribution of IRD categories differed between the two cohorts: the post-COVID-19 cohort had a higher percentage of patients classified as having inflammatory joint diseases (IJD, 52.5% vs 37.2%, p=0.013) while the post-vaccine cohort had a higher prevalence of patients classified as polymyalgia rheumatica (PMR, 33.1% vs 21.3%, p=0.032). No differences were detected in the percentage of patients diagnosed with connective tissue diseases (CTD 19.7% vs 20.7%, p=0.837) or vasculitis (6.6% vs 9.0%, p=0.467). Despite the short follow-up period, IJD and PMR patients' response to first-line therapy was favourable, with both groups achieving a drop in baseline disease activity scores of ~30% and ~70% respectively.Our article reports the largest cohort published to date of new-onset IRD following SARS-CoV-2 infection or COVID-19 vaccines. Although causality cannot be ascertained, the spectrum of possible clinical manifestations is broad and includes IJD, PMR, CTD and vasculitis." @default.
- W4380991779 created "2023-06-17" @default.
- W4380991779 creator A5002460746 @default.
- W4380991779 creator A5003030575 @default.
- W4380991779 creator A5004955353 @default.
- W4380991779 creator A5011583819 @default.
- W4380991779 creator A5015866814 @default.
- W4380991779 creator A5019939650 @default.
- W4380991779 creator A5027512145 @default.
- W4380991779 creator A5030230179 @default.
- W4380991779 creator A5030868203 @default.
- W4380991779 creator A5032417893 @default.
- W4380991779 creator A5034643922 @default.
- W4380991779 creator A5034711738 @default.
- W4380991779 creator A5035626409 @default.
- W4380991779 creator A5036516700 @default.
- W4380991779 creator A5045036487 @default.
- W4380991779 creator A5051871418 @default.
- W4380991779 creator A5052016973 @default.
- W4380991779 creator A5054047592 @default.
- W4380991779 creator A5054791712 @default.
- W4380991779 creator A5055967355 @default.
- W4380991779 creator A5057441594 @default.
- W4380991779 creator A5063646430 @default.
- W4380991779 creator A5064846220 @default.
- W4380991779 creator A5067342132 @default.
- W4380991779 creator A5068064448 @default.
- W4380991779 creator A5074740002 @default.
- W4380991779 creator A5075511405 @default.
- W4380991779 creator A5076632964 @default.
- W4380991779 creator A5077373247 @default.
- W4380991779 creator A5078087305 @default.
- W4380991779 creator A5078263316 @default.
- W4380991779 creator A5078370156 @default.
- W4380991779 creator A5081273285 @default.
- W4380991779 creator A5085007757 @default.
- W4380991779 creator A5087539243 @default.
- W4380991779 creator A5088320250 @default.
- W4380991779 creator A5089293243 @default.
- W4380991779 creator A5091331495 @default.
- W4380991779 creator A5092189205 @default.
- W4380991779 date "2023-06-01" @default.
- W4380991779 modified "2023-10-18" @default.
- W4380991779 title "Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group" @default.
- W4380991779 cites W1863443652 @default.
- W4380991779 cites W2054764131 @default.
- W4380991779 cites W2110177517 @default.
- W4380991779 cites W2110606983 @default.
- W4380991779 cites W2120197181 @default.
- W4380991779 cites W2139235644 @default.
- W4380991779 cites W2232051223 @default.
- W4380991779 cites W2589291012 @default.
- W4380991779 cites W2601656232 @default.
- W4380991779 cites W2737622719 @default.
- W4380991779 cites W2967488951 @default.
- W4380991779 cites W3017125154 @default.
- W4380991779 cites W3027961469 @default.
- W4380991779 cites W3029872328 @default.
- W4380991779 cites W3038214791 @default.
- W4380991779 cites W3110066205 @default.
- W4380991779 cites W3112311473 @default.
- W4380991779 cites W3136955306 @default.
- W4380991779 cites W3165152618 @default.
- W4380991779 cites W3193449606 @default.
- W4380991779 cites W3200260215 @default.
- W4380991779 cites W3203515650 @default.
- W4380991779 cites W3207724482 @default.
- W4380991779 cites W3212266659 @default.
- W4380991779 cites W3215472813 @default.
- W4380991779 cites W4200092905 @default.
- W4380991779 cites W4200097038 @default.
- W4380991779 cites W4200198501 @default.
- W4380991779 cites W4200255055 @default.
- W4380991779 cites W4200531913 @default.
- W4380991779 cites W4205760778 @default.
- W4380991779 cites W4207076468 @default.
- W4380991779 cites W4210631536 @default.
- W4380991779 cites W4211030351 @default.
- W4380991779 cites W4213179732 @default.
- W4380991779 cites W4220833145 @default.
- W4380991779 cites W4221024504 @default.
- W4380991779 cites W4221107345 @default.
- W4380991779 cites W4221115880 @default.
- W4380991779 cites W4223608444 @default.
- W4380991779 cites W4224879662 @default.
- W4380991779 cites W4225135656 @default.
- W4380991779 cites W4225293614 @default.
- W4380991779 cites W4226023710 @default.
- W4380991779 cites W4280511746 @default.
- W4380991779 cites W4283395367 @default.
- W4380991779 cites W4292528167 @default.
- W4380991779 cites W4294084523 @default.
- W4380991779 cites W4294091548 @default.
- W4380991779 cites W4295498029 @default.
- W4380991779 cites W4304128408 @default.
- W4380991779 cites W4307129319 @default.
- W4380991779 cites W4308510590 @default.
- W4380991779 cites W4308844393 @default.